Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Institute on Drug Abuse (NIDA)
This is a double-blind, placebo-controlled, parallel group design study to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.
Age
18–99
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participant must have DSM-IV diagnosis of cocaine dependence as determined by SCID.
Must be seeking treatment for cocaine dependence.
Must be able to understand and provide written informed consent.
You may not be if
Please contact the study site for more information.
Clareo Health | Modafinil for the Treatment of Cocaine Dependence - 1
